Abstract: Introduction Aging United States Military Veterans are at an increased risk of developing dementia compared to the general population due to both military and …
Abstract: Background: Several amyloid targeting therapies have been approved for Alzheimer's disease (AD), including lecanemab (Leqembi). However, real-world implementation of …